GEVIMIS Trademark

Trademark Overview

On Friday, October 4, 2019, a trademark application was filed for GEVIMIS with the United States Patent and Trademark Office. The USPTO has given the GEVIMIS trademark a serial number of 79273121. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Monday, July 13, 2020. This trademark is owned by NOVARTIS AG. The GEVIMIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of cancer and tumors
gevimis

General Information

Serial Number79273121
Word MarkGEVIMIS
Filing DateFriday, October 4, 2019
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateMonday, July 13, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 4, 2020

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of cancer and tumors

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateMonday, July 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Sunday, May 23, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, April 28, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 28, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sunday, October 25, 2020NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, October 24, 2020DEATH OF INTERNATIONAL REGISTRATION
Monday, July 13, 2020ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Monday, July 13, 2020ABANDONMENT - AFTER PUBLICATION
Sunday, July 12, 2020TEAS EXPRESS ABANDONMENT RECEIVED
Wednesday, July 8, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 8, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 8, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, July 8, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 8, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 8, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 3, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 4, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 4, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 28, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 23, 2019ASSIGNED TO EXAMINER
Thursday, December 12, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 12, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, December 7, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, December 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 2, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 28, 2019SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

gevimis cancer tumors treatment prevention products pharmaceutical